[64Cu]TREM1-mAb

N/A

Report date: 2025/10/30 15:24:38

Base Information

Drug Name[64Cu]TREM1-mAb

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionTriggering receptor expressed on myeloid cells 1 binders

TargetsTriggering receptor expressed on myeloid cells 1

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesStanford University

China Registration ClassN/A

Develop Information

Active CompaniesStanford University

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A